These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 15249548)

  • 1. Impaired endothelial release of tissue-type plasminogen activator in patients with chronic kidney disease and hypertension.
    Hrafnkelsdóttir T; Ottosson P; Gudnason T; Samuelsson O; Jern S
    Hypertension; 2004 Sep; 44(3):300-4. PubMed ID: 15249548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release of tissue-type plasminogen activator in response to muscarinic receptor stimulation in human forearm.
    Jern S; Selin L; Bergbrant A; Jern C
    Thromb Haemost; 1994 Oct; 72(4):588-94. PubMed ID: 7878638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelium-dependent vasodilation and tissue-type plasminogen activator release in borderline hypertension.
    Jern S; Wall U; Bergbrant A; Selin-Sjögren L; Jern C
    Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3376-83. PubMed ID: 9437182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preserved tissue-type plasminogen activator release and endothelium-dependent vasodilation in postmenopausal women with NIDDM.
    Manhem K; Dotevall A; Wilhelmsen L; Jern S
    J Diabetes Complications; 2000; 14(3):127-34. PubMed ID: 10989320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinolytic capacity increases with age in healthy humans, while endothelium-dependent vasodilation is unaffected.
    Gudnason T; Hrafnkelsdóttir T; Wall U; Swedberg K; Jern S
    Thromb Haemost; 2003 Feb; 89(2):374-81. PubMed ID: 12574819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High capacity for tissue-type plasminogen activator release from vascular endothelium in vivo.
    Wall U; Jern C; Jern S
    J Hypertens; 1997 Dec; 15(12 Pt 2):1641-7. PubMed ID: 9488216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-arterial tumor necrosis factor-alpha impairs endothelium-dependent vasodilatation and stimulates local tissue plasminogen activator release in humans.
    Chia S; Qadan M; Newton R; Ludlam CA; Fox KA; Newby DE
    Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):695-701. PubMed ID: 12692009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide modulates tissue plasminogen activator release in normotensive subjects and hypertensive patients.
    Giannarelli C; De Negri F; Virdis A; Ghiadoni L; Cipriano A; Magagna A; Taddei S; Salvetti A
    Hypertension; 2007 Apr; 49(4):878-84. PubMed ID: 17339540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired capacity for stimulated fibrinolysis in primary hypertension is restored by antihypertensive therapy.
    Ridderstråle W; Ulfhammer E; Jern S; Hrafnkelsdóttir T
    Hypertension; 2006 Apr; 47(4):686-91. PubMed ID: 16520399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smoking impairs bradykinin-stimulated t-PA release.
    Pretorius M; Rosenbaum DA; Lefebvre J; Vaughan DE; Brown NJ
    Hypertension; 2002 Mar; 39(3):767-71. PubMed ID: 11897760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marked impairment of protease-activated receptor type 1-mediated vasodilation and fibrinolysis in cigarette smokers: smoking, thrombin, and vascular responses in vivo.
    Lang NN; Gudmundsdóttir IJ; Boon NA; Ludlam CA; Fox KA; Newby DE
    J Am Coll Cardiol; 2008 Jul; 52(1):33-9. PubMed ID: 18582632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylcholine-mediated vasodilatation and tissue-type plasminogen activator release in normal and hypertensive men.
    Dell'Omo G; Ferrini L; Morale M; De Negri F; Melillo E; Carmassi F; Pedrinelli R
    Angiology; 1999 Apr; 50(4):273-82. PubMed ID: 10225462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of local tissue-type plasminogen activator release by endothelium-dependent and endothelium-independent agonists in human vasculature.
    Stein CM; Brown N; Vaughan DE; Lang CC; Wood AJ
    J Am Coll Cardiol; 1998 Jul; 32(1):117-22. PubMed ID: 9669258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of a local mechanism for desmopressin-induced tissue-type plasminogen activator release in human forearm.
    Wall U; Jern S; Tengborn L; Jern C
    Blood; 1998 Jan; 91(2):529-37. PubMed ID: 9427706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired capacity for endogenous fibrinolysis in essential hypertension.
    Hrafnkelsdóttir T; Wall U; Jern C; Jern S
    Lancet; 1998 Nov; 352(9140):1597-8. PubMed ID: 9843110
    [No Abstract]   [Full Text] [Related]  

  • 16. In vivo release of tissue-type plasminogen activator across the human forearm during mental stress.
    Jern C; Selin L; Jern S
    Thromb Haemost; 1994 Aug; 72(2):285-91. PubMed ID: 7831666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An in vivo model for the assessment of acute fibrinolytic capacity of the endothelium.
    Newby DE; Wright RA; Ludlam CA; Fox KA; Boon NA; Webb DJ
    Thromb Haemost; 1997 Oct; 78(4):1242-8. PubMed ID: 9364992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular nucleotides ATP and UTP induce a marked acute release of tissue-type plasminogen activator in vivo in man.
    Hrafnkelsdóttir T; Erlinge D; Jern S
    Thromb Haemost; 2001 May; 85(5):875-81. PubMed ID: 11372682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute hypertension impairs endothelium-dependent vasodilation.
    Millgård J; Lind L
    Clin Sci (Lond); 1998 Jun; 94(6):601-7. PubMed ID: 9854457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sulfaphenazole on tissue plasminogen activator release in normotensive subjects and hypertensive patients.
    Giannarelli C; Virdis A; De Negri F; Magagna A; Duranti E; Salvetti A; Taddei S
    Circulation; 2009 Mar; 119(12):1625-33. PubMed ID: 19289643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.